Guo R, Pandey A, Chandramouli C, Wu MZ, et al. The effect of sodium-glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM. Diabetes Obes Metab 2025;27:4720-4728.
PMID: 40511485